Showing 21 - 40 results of 151,373 for search '"Pharmaceutical"', query time: 0.58s Refine Results
  1. 21
  2. 22

    Genotoxic impurities in pharmaceutical products – regulatory, toxicological and pharmaceutical considerations by Katarzyna Regulska, Marcin Michalak, Marek Murias, Beata Stanisz

    Published 2021-03-01
    “…This article provides an overview of the most important aspects around the detecting and reporting of genotoxic impurities in the pharmaceutical industry. It focuses on relevant regulatory, toxicological, and pharmaceutical considerations. …”
    Get full text
    Article
  3. 23
  4. 24
  5. 25
  6. 26
  7. 27
  8. 28
  9. 29

    Influence of the Pharmaceutical Law Amendment on the Pharmaceutical Market in Poland. Selected Aspects by Agnieszka Woś

    Published 2007-06-01
    “…This paper presents the process of turnover the medicaments between pharmaceutical market that is shaped by amendment of pharmaceutical law. …”
    Get full text
    Article
  10. 30

    Implementation of aid as pharmaceutical innovation towards national and foreign pharmaceutical practice by L. M. Unhurian, O. I. Bielyaieva, I. B. Pietkova

    Published 2017-02-01
    Subjects: “…pharmaceutical care, pharmaceutical specialist, pharmacotherapy, drugs, online pharmacies…”
    Get full text
    Article
  11. 31
  12. 32
  13. 33

    Motivation of obtaining higher pharmaceutical education of students of the National Pharmaceutical University by A. A. Kotvitska, N. V. Zhyvora, O. S. Ovakimyan

    Published 2018-08-01
    “…The subject of the study is students of the National Pharmaceutical University 1 course of pharmaceutical faculties N 1, N 2, N 3. …”
    Get full text
    Article
  14. 34

    Role of pharmaceutical information in formation of competent consumer behaviour in the pharmaceutical market by T P Lagutkina, E I Gribkova, M M Kurashov, A K Sobolenko

    Published 2013-12-01
    “…Competent use of pharmaceutical information by doctors, pharmaceutical experts and consumers allows to avoid possible high risk mistakes for health and life of the patient.…”
    Get full text
    Article
  15. 35

    Comparison of R&D information disclosure of Chinese and foreign listed pharmaceutical enterprises – Take Hengrui Pharmaceutical and Pfizer Pharmaceutical as examples by Cai Yating

    Published 2023-01-01
    “…Based on the actual situation, a detailed analysis of the Chinese enterprise Hengrui Pharmaceutical and the American enterprise Pfizer Pharmaceutical, the R&D expenditure and the disclosure of R&D expenses of the company in recent years were explained, and the problems and the gap between the two enterprises were found. …”
    Get full text
    Article
  16. 36
  17. 37
  18. 38
  19. 39
  20. 40